1. Home
  2. WOLF vs WVE Comparison

WOLF vs WVE Comparison

Compare WOLF & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOLF
  • WVE
  • Stock Information
  • Founded
  • WOLF 1987
  • WVE 2012
  • Country
  • WOLF United States
  • WVE Singapore
  • Employees
  • WOLF N/A
  • WVE N/A
  • Industry
  • WOLF Semiconductors
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • WOLF Technology
  • WVE Health Care
  • Exchange
  • WOLF Nasdaq
  • WVE Nasdaq
  • Market Cap
  • WOLF 978.5M
  • WVE 939.3M
  • IPO Year
  • WOLF 1993
  • WVE 2015
  • Fundamental
  • Price
  • WOLF $3.28
  • WVE $6.59
  • Analyst Decision
  • WOLF Hold
  • WVE Strong Buy
  • Analyst Count
  • WOLF 14
  • WVE 11
  • Target Price
  • WOLF $10.67
  • WVE $20.91
  • AVG Volume (30 Days)
  • WOLF 30.2M
  • WVE 1.7M
  • Earning Date
  • WOLF 05-08-2025
  • WVE 05-08-2025
  • Dividend Yield
  • WOLF N/A
  • WVE N/A
  • EPS Growth
  • WOLF N/A
  • WVE N/A
  • EPS
  • WOLF N/A
  • WVE N/A
  • Revenue
  • WOLF $761,300,000.00
  • WVE $104,939,000.00
  • Revenue This Year
  • WOLF N/A
  • WVE N/A
  • Revenue Next Year
  • WOLF $26.83
  • WVE N/A
  • P/E Ratio
  • WOLF N/A
  • WVE N/A
  • Revenue Growth
  • WOLF N/A
  • WVE N/A
  • 52 Week Low
  • WOLF $2.06
  • WVE $4.25
  • 52 Week High
  • WOLF $30.86
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • WOLF 46.23
  • WVE 42.81
  • Support Level
  • WOLF $3.22
  • WVE $5.62
  • Resistance Level
  • WOLF $4.60
  • WVE $6.73
  • Average True Range (ATR)
  • WOLF 0.51
  • WVE 0.61
  • MACD
  • WOLF 0.15
  • WVE 0.07
  • Stochastic Oscillator
  • WOLF 36.61
  • WVE 34.84

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: